AR |
Androgen receptor |
AR-V7 |
AR splice variant 7 |
Enz |
Enzalutamide |
Abi |
Abiraterone |
CTC |
Circulating tumor cells |
DTX |
Docetaxel |
CBZ |
Cabazitaxel |
RT-PCR |
Real-time polymerase chain reaction |
cDNA |
Complementary DNA |
CRPC |
Castration-resistant prostate cancer |
nmCRPC |
Non-metastatic CRPC |
mCRPC |
Metastatic CRPC |
CTC |
Circulating tumor cells |
mRNA |
Messenger ribonucleic acid |
ALP |
Alkaline phosphatase |
LDH |
Lactate dehydrogenase |
Alb |
Albumin |
Hb |
Hemoglobin |
GS |
Gleason score |
EDTA |
Ethylene-diamine-tetra-acetic acid |
RT |
Reverse transcription |
OS |
Overall survival |
PSA |
Prostate-specific antigen |
GAPDH |
Glyceraldehyde 3-phosphate dehydrogenase |
EOD |
Extent of disease |
PBMC |
Peripheral Blood Mononuclear Cells |
JHU |
Johns Hopkins Hospital |
PCWG |
Prostate Cancer Clinical Trials Working Group |
RBC |
red blood cell |
BSA |
Bovine Serum Albumin |
BSA |
Bovine Serum Albumin |
PBS |
Phosphate-Buffered Saline |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
Ct |
Threshold Cycle |
SD |
Standard Deviation |
HR |
Hezard Ratio |
PSMA |
Prostate Specific Membrane Antigen |
EGFR |
Epidermal growth factor receptor |
DAPI |
4’,6-diamidino-2-phenylindole |
FACS |
fluorescence-activated cell sorting |